IGC Pharma (IGC) Change in Account Payables (2010 - 2025)
IGC Pharma (IGC) reported Change in Account Payables of -$303000.0 for Q3 2025, down 15050.0% year-over-year from N/an in Q3 2024, and down 694.12% quarter-over-quarter from $51000.0 in Q2 2025.
IGC Pharma (IGC) Change in Account Payables (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Change in Account Payables data on file, last reported at -$303000.0 in Q3 2025.
- Change in Account Payables for Q3 2025 came in at -$303000.0, down 15050.0% year-over-year; the trailing twelve-month figure through Sep 2025 was -$141000.0 (down 164.09% YoY), and the FY2026 annual result was $241000.0, up 127.36% from the prior year.
- Change in Account Payables fell to -$303000.0 in Q3 2025 per IGC's latest filing, from $51000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $261000.0 in Q1 2021 and troughed at -$524000.0 in Q2 2022.
- A 5-year average of -$12277.8 and a median of $26500.0 in 2022 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 2650.0% in 2025 and fell as far as 15050.0% in 2025.
- A 5-year view of Change in Account Payables shows it stood at -$123000.0 in 2021, then jumped by 106.5% to $8000.0 in 2022, then soared by 1125.0% to $98000.0 in 2023, then plunged by 32.65% to $66000.0 in 2024, then sank by 559.09% to -$303000.0 in 2025.
- Business Quant data shows IGC's Change in Account Payables at -$303000.0 in Q3 2025, $51000.0 in Q2 2025, and $45000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -9.42 Mn |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -303,000.00 |
| Sep 30, 2025 | -303,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 45,000.00 |
| Mar 31, 2025 | 45,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 126,000.00 |
| Mar 31, 2024 | 126,000.00 |
| Dec 31, 2023 | 98,000.00 |
| Dec 31, 2023 | 98,000.00 |
| Sep 30, 2023 | -123,000.00 |
| Sep 30, 2023 | -123,000.00 |
| Jun 30, 2023 | 142,000.00 |
| Jun 30, 2023 | 142,000.00 |